Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil vs Cyclophosphamide for ANCA-Associated Vasculitis Relapse
NCT00103792Phase 3Completed
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2004
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mycophenolate mofetil in Antineutrophil cytoplasmic antibody-associated vasculitis (AAV), sponsored by University Medical Center Groningen. Started Dec 2004; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on NCT00103792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103792.